)
10X Genomics (TXG) investor relations material
10X Genomics Bank of America Global Healthcare Conference 2026 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Business performance and financial highlights
Achieved strong double-digit growth in single-cell and spatial consumables revenue, with volume increases offsetting pricing declines.
Improved operating profile through cost control, resulting in increased cash position and a stronger balance sheet.
Q2 and Q3 expected to see a step down in revenue, with a substantial increase in Q4 driven by Atera placements.
Annual guidance reinstated, reflecting anticipated double-digit growth in single-cell reactions and spatial consumables.
Confident in meeting guidance, with Q4 expected to show a 17-18% sequential revenue increase.
Atera platform launch and market impact
Launched Atera, the largest platform launch in company history, designed to break through throughput and sensitivity constraints in spatial biology.
Atera offers high throughput, whole transcriptome capability, and works with standard glass slides, enabling large-scale translational studies.
Strong initial demand for Atera, with supply constraints limiting shipments to 40 units in the second half of the year, mostly in Q4.
Early placements prioritized for high-utilization customers, including existing Xenium users and centralized service providers.
Expectation that Atera will eventually consolidate the spatial portfolio, though legacy platforms will remain relevant in the near term.
Strategic outlook and future initiatives
Investments in manufacturing capacity are moderate, leveraging existing infrastructure in Pleasanton and Singapore.
Consumables margins for Atera designed to be accretive, with margin mix expected to improve as the installed base grows.
Anticipate higher utilization rates for Atera due to its centralized model and higher pull-through potential.
Roadmap includes further automation, multi-omics (including proteins), and advanced software/AI capabilities.
Clinical diagnostics seen as a major future opportunity, with technology advances enabling large-scale clinical evidence generation.
- Q1 revenue up 9% adjusted, gross margin at 70%, and Atera launch drives strong demand.TXG
Q1 20268 May 2026 - 2026 proxy covers director elections, auditor ratification, and executive pay, with strong governance focus.TXG
Proxy filing24 Apr 2026 - Director elections, auditor ratification, and executive pay are up for vote at the annual meeting.TXG
Proxy filing24 Apr 2026 - Atera delivers high-throughput, single-cell spatial transcriptomics with unmatched flexibility.TXG
Corporate presentation19 Apr 2026 - Consumables growth and cost discipline drove revenue above guidance as losses narrowed.TXG
Q4 202513 Apr 2026 - Innovation and strong cash flow drive growth amid macro challenges and evolving customer needs.TXG
TD Cowen 46th Annual Health Care Conference3 Mar 2026 - Spatial consumables growth drove 4% revenue gain; 2024 guidance lowered amid macro headwinds.TXG
Q2 20242 Feb 2026 - Strong product launches and sales reorganization position the company for scalable growth.TXG
Morgan Stanley 22nd Annual Global Healthcare Conference22 Jan 2026 - Q3 2024 revenue fell 1%, with strong consumables growth and new launches amid market headwinds.TXG
Q3 202418 Jan 2026
Next 10X Genomics earnings date
Next 10X Genomics earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Explore our global coverage